Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yang H et al. – Ready translation of this depletion strategy to improve ex vivo CB expansion in the clinic is feasible as clinical–grade devices and reagents are available. Ultimately, the aim of improving TNC and CD34+ transplant doses is to further improve the rate of neutrophil and platelet engraftment in CB recipients.

Related Articles

History of cord blood transplantation
Bone Marrow Transplantation, 10/07/09    Relevance Score: 84%

Differences in Circulating Dendritic Cell Subtypes in Pregnant Women, Cord Blood and Healthy Adult Women
Journal of Korean Medical Science, 10/15/09    Relevance Score: 82%

The use of cord blood for transfusion purposes: current status
Vox Sanguinis, 10/15/09    Relevance Score: 81%

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Arthritis Research & Therapy, 10/14/09    Relevance Score: 81%

Ex vivo expanded cord blood CD4 T lymphocytes exhibit a distinct expression profile of cytokine-related genes from those of peripheral blood origin
Immunology, 10/13/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address